MBTPS1 and neoplasm: Enhanced ceramide-S1P signalling may be mediating ARSI resistance induced by AR gain, as men with mCRPC had significantly shorter ARSI treatment duration if their tumours had AR gain in combination with increased expression of sphingolipid genes (involved in ceramide-S1P signalling) [16].